{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:24:29Z","timestamp":1780395869256,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T00:00:00Z","timestamp":1243555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11739-009-0261-4","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T16:19:45Z","timestamp":1243527585000},"page":"297-308","source":"Crossref","is-referenced-by-count":28,"title":["The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine"],"prefix":"10.1007","volume":"4","author":[{"given":"Paolo","family":"Ventura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Domenica","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,29]]},"reference":[{"key":"261_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(05)17744-7","volume":"365","author":"R Kauppinen","year":"2005","unstructured":"Kauppinen R (2005) Porphyrias. Lancet 365:241\u2013252","journal-title":"Lancet"},{"key":"261_CR2","first-page":"2301","volume-title":"Teodori 2000","author":"E Ventura","year":"2001","unstructured":"Ventura E, Rocchi E (2001) Le Porfirie. In: Guarini G, Fiorelli G, Malliani A, Violi E, Volpe M (eds) Teodori 2000. Trattato di Medicina Interna.Societ\u00e0 Editrice Universo, Roma, pp 2301\u20132334"},{"key":"261_CR3","first-page":"2991","volume-title":"The metabolic and molecular basis of inherited diseases","author":"KE Anderson","year":"2001","unstructured":"Anderson KE, Sassa S, Bishop DF, Desnick RJ (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited diseases. McGraw-Hill, New York, pp 2991\u20133062"},{"key":"261_CR4","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","volume":"104","author":"JD Phillips","year":"2007","unstructured":"Phillips JD, Bergonia HA, Reilly CA et al (2007) A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci USA 104:5079\u20135084","journal-title":"Proc Natl Acad Sci USA"},{"key":"261_CR5","first-page":"326","volume":"68","author":"JC Rigal","year":"2002","unstructured":"Rigal JC, Blanloeil Y (2002) Anaesthesia and porphyria. Minerva Anestesiol 68:326\u2013331","journal-title":"Minerva Anestesiol"},{"key":"261_CR6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","volume":"39","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R (2003) Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatol 39:620\u2013627","journal-title":"J Hepatol"},{"key":"261_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10545-005-8050-3","volume":"28","author":"MN Badminton","year":"2005","unstructured":"Badminton MN, Elder GH (2005) Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis 28:277\u2013286","journal-title":"J Inherit Metab Dis"},{"key":"261_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00439-003-1059-5","volume":"114","author":"L Gouya","year":"2004","unstructured":"Gouya L, Puy H, Robreau AM et al (2004) Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet 114:256\u2013262","journal-title":"Hum Genet"},{"key":"261_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1586\/14737159.4.2.243","volume":"4","author":"R Kauppinen","year":"2004","unstructured":"Kauppinen R (2004) Molecular diagnostics of acute intermittent porphyria. Expert Rev Mol Diagn 4:243\u2013249","journal-title":"Expert Rev Mol Diagn"},{"key":"261_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2007-1007141","volume":"18","author":"HL Bonkovsky","year":"1998","unstructured":"Bonkovsky HL, Barnard GF (1998) Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology. Semin Liver Dis 18:57\u201365","journal-title":"Semin Liver Dis"},{"key":"261_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-08-092388-8.50015-7","volume-title":"The porphyrin handbook","author":"WM Rooij de","year":"2003","unstructured":"de Rooij WM, Edixhoven A, Wilson JH (2003) Porphyria: a diagnostic approach. In: Kadish KM, Smith KM, Guillard R (eds) The porphyrin handbook. Elsevier, St Louis, pp 211\u2013245"},{"key":"261_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10545-006-0155-9","volume":"29","author":"U Grob","year":"2006","unstructured":"Grob U, Puy H, Jacob K et al (2006) Biochemical compared to molecular diagnosis in acute intermittent porphyria. J Inherit Metab Dis 29:157\u2013161","journal-title":"J Inherit Metab Dis"},{"key":"261_CR13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(96)09070-8","volume":"349","author":"GH Elder","year":"1997","unstructured":"Elder GH, Hift RJ, Meissner PN (1997) The acute porphyrias. Lancet 349:1613\u20131617","journal-title":"Lancet"},{"key":"261_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jocn.2006.11.015","volume":"15","author":"C Solinas","year":"2008","unstructured":"Solinas C, Vajda FJ (2008) Neurological complications of porphyria. J Clin Neurosci 15:263\u2013268","journal-title":"J Clin Neurosci"},{"key":"261_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-1007138","volume":"18","author":"RE Kirsch","year":"1998","unstructured":"Kirsch RE, Meissner PN, Hift RJ (1998) Variegate porphyria. Semin Liver Dis 18:33\u201341","journal-title":"Semin Liver Dis"},{"key":"261_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2007-1007137","volume":"18","author":"P Martasek","year":"1998","unstructured":"Martasek P (1998) Hereditary coproporphyria. Semin Liver Dis 18:25\u201332","journal-title":"Semin Liver Dis"},{"key":"261_CR17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-1007145","volume":"18","author":"S Sassa","year":"1998","unstructured":"Sassa S (1998) ALAD porphyria. Semin Liver Dis 18:95\u2013101","journal-title":"Semin Liver Dis"},{"key":"261_CR18","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0140-6736(05)67893-2","volume":"366","author":"D Frith","year":"2005","unstructured":"Frith D, Yeung K, Thrush S et al (2005) Lead poisoning\u2014a differential diagnosis for abdominal pain. Lancet 366:2146","journal-title":"Lancet"},{"key":"261_CR19","first-page":"418","volume":"45","author":"C Usalan","year":"1996","unstructured":"Usalan C, Erdem Y, Altun B et al (1996) Severe hyponatremia due to SIADH provoked by acute intermittent porphyria. Clin Nephrol 45:418","journal-title":"Clin Nephrol"},{"key":"261_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.62.4.319","volume":"62","author":"HL Crimlisk","year":"1997","unstructured":"Crimlisk HL (1997) The little imitator\u2013porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 62:319\u2013328","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"261_CR21","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.142.12.1430","volume":"142","author":"PV Tishler","year":"1985","unstructured":"Tishler PV, Woodward B, O\u2019Connor J et al (1985) High prevalence of intermittent acute porphyria in a psychiatric patient population. Am J Psychiatry 142:1430\u20131436","journal-title":"Am J Psychiatry"},{"key":"261_CR22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1651-2227.2003.tb02507.x","volume":"92","author":"J Hultdin","year":"2003","unstructured":"Hultdin J, Schmauch A, Wikberg A et al (2003) Acute intermittent porphyria in childhood: a population-based study. Acta Paediatr 92:562\u2013568","journal-title":"Acta Paediatr"},{"key":"261_CR23","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/clinchem\/48.11.1891","volume":"48","author":"R Kauppinen","year":"2002","unstructured":"Kauppinen R, von und zu Fraunberg M (2002) Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem 48:1891\u20131900","journal-title":"Clin Chem"},{"key":"261_CR24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006254-198904000-00003","volume":"44","author":"C Kanaan","year":"1989","unstructured":"Kanaan C, Veille JC, Lakin M (1989) Pregnancy and acute intermittent porphyria. Obstet Gynecol Surv 44:244\u2013249","journal-title":"Obstet Gynecol Surv"},{"issue":"Suppl 2","key":"261_CR25","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.33549\/physiolres.930000.55.S2.67","volume":"55","author":"JC Deybach","year":"2006","unstructured":"Deybach JC, Badminton M, Puy H et al (2006) European porphyria initiative (EPI): a platform to develop a common approach to the management of porphyrias and to promote research in the field. Physiol Res 55(Suppl 2):S67\u2013S73","journal-title":"Physiol Res"},{"key":"261_CR26","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/bmj.320.7250.1647","volume":"320","author":"H Thadani","year":"2000","unstructured":"Thadani H, Deacon A, Peters T (2000) Diagnosis and management of porphyria. BMJ 320:1647\u20131651","journal-title":"BMJ"},{"key":"261_CR27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2796.1994.tb01279.x","volume":"236","author":"C Andersson","year":"1994","unstructured":"Andersson C, Lithner F (1994) Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med 236:169\u2013175","journal-title":"J Intern Med"},{"key":"261_CR28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","volume":"32","author":"C Andant","year":"2000","unstructured":"Andant C, Puy H, Bogard C et al (2000) Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 32:933\u2013939","journal-title":"J Hepatol"},{"key":"261_CR29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02110039","volume":"27","author":"H Verneuil de","year":"1995","unstructured":"de Verneuil H, Ged C, Boulechfar S, Moreau-Gaudry F (1995) Porphyrias: animal models and prospects for cellular and gene therapy. J Bioenerg Biomembr 27:239\u2013248","journal-title":"J Bioenerg Biomembr"},{"key":"261_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/B:BOLI.0000028795.84156.da","volume":"27","author":"E Rocchi","year":"2004","unstructured":"Rocchi E, Ventura P, Ronzoni A et al (2004) Pro-oxidant and antioxidant factors in acute intermittent porphyria: family studies. J Inherit Metab Dis 27:251\u2013266","journal-title":"J Inherit Metab Dis"},{"key":"261_CR31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1172\/JCI5986","volume":"103","author":"RL Lindberg","year":"1999","unstructured":"Lindberg RL, Martini R, Baumgartner M et al (1999) Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J Clin Invest 103:1127\u20131134","journal-title":"J Clin Invest"},{"key":"261_CR32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/lt.21261","volume":"13","author":"AK Seth","year":"2007","unstructured":"Seth AK, Badminton MN, Mirza D et al (2007) Liver transplantation for porphyria: who, when, and how? Liver Transpl 13:1219\u20131227","journal-title":"Liver Transpl"},{"key":"261_CR33","first-page":"576","volume":"49","author":"BC Shanley","year":"1975","unstructured":"Shanley BC, Neethling AC, Percy VA, Carstens M (1975) Neurochemical aspects of porphyria: studies on the possible neurotoxicity of delta-aminolaevulinic acid. S Afr Med J 49:576\u2013580","journal-title":"S Afr Med J"},{"key":"261_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(86)90258-5","volume":"161","author":"EI Minder","year":"1986","unstructured":"Minder EI (1986) Measurement of 5-aminolaevulinic acid by reversed phase HPLC and fluorescence detection. Clin Chim Acta 161:11\u201318","journal-title":"Clin Chim Acta"},{"key":"261_CR35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1373\/clinchem.2003.025213","volume":"50","author":"RJ Hift","year":"2004","unstructured":"Hift RJ, Davidson BP, van der Hooft C et al (2004) Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard. Clin Chem 50:915\u2013923","journal-title":"Clin Chem"},{"key":"261_CR36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/003655100448383","volume":"60","author":"EJ Erlandsen","year":"2000","unstructured":"Erlandsen EJ, Jorgensen PE, Markussen S, Brock A (2000) Determination of porphobilinogen deaminase activity in human erythrocytes: pertinent factors in obtaining optimal conditions for measurements. Scand J Clin Lab Invest 60:627\u2013634","journal-title":"Scand J Clin Lab Invest"},{"key":"261_CR37","first-page":"335","volume":"53","author":"BC Campbell","year":"1977","unstructured":"Campbell BC, Brodie MJ, Thompson GG et al (1977) Alterations in the activity of enzymes of haem biosynthesis in lead poisoning and acute hepatic prophyria. Clin Sci Mol Med 53:335\u2013340","journal-title":"Clin Sci Mol Med"},{"key":"261_CR38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1373\/clinchem.2005.058198","volume":"52","author":"Y Floderus","year":"2006","unstructured":"Floderus Y, Sardh E, Moller C et al (2006) Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Clin Chem 52:701\u2013707","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"261_CR39","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.33549\/physiolres.930000.55.S2.43","volume":"55","author":"S Thunell","year":"2006","unstructured":"Thunell S (2006) (Far) Outside the box: genomic approach to acute porphyria. Physiol Res 55(Suppl 2):S43\u2013S66","journal-title":"Physiol Res"},{"key":"261_CR40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/bcmd.2001.0478","volume":"28","author":"MD Cappellini","year":"2002","unstructured":"Cappellini MD, Martinez di Montemuros F, Di Pierro E, Fiorelli G (2002) Hematologically important mutations: acute intermittent porphyria. Blood Cells Mol Dis 28:5\u201312","journal-title":"Blood Cells Mol Dis"},{"key":"261_CR41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.12968\/hosp.2001.62.7.1613","volume":"62","author":"GH Elder","year":"2001","unstructured":"Elder GH, Hift RJ (2001) Treatment of acute porphyria. Hosp Med 62:422\u2013425","journal-title":"Hosp Med"},{"key":"261_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199201000-00001","volume":"71","author":"R Kauppinen","year":"1992","unstructured":"Kauppinen R, Mustajoki P (1992) Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine (Baltimore) 71:1\u201313","journal-title":"Medicine (Baltimore)"},{"key":"261_CR43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2005.06.040","volume":"122","author":"C Handschin","year":"2005","unstructured":"Handschin C, Lin J, Rhee J et al (2005) Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122:505\u2013515","journal-title":"Cell"},{"key":"261_CR44","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/jhep.2001.24170","volume":"33","author":"MM Schuurmans","year":"2001","unstructured":"Schuurmans MM, Hoffmann F, Lindberg RL, Meyer UA (2001) Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria. Hepatology 33:1217\u20131222","journal-title":"Hepatology"},{"key":"261_CR45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.45.3.594","volume":"45","author":"GL Krauss","year":"1995","unstructured":"Krauss GL, Simmons-O\u2019Brien E, Campbell M (1995) Successful treatment of seizures and porphyria with gabapentin. Neurology 45:594\u2013595","journal-title":"Neurology"},{"key":"261_CR46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJM198409063111006","volume":"311","author":"KE Anderson","year":"1984","unstructured":"Anderson KE, Spitz IM, Sassa S et al (1984) Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med 311:643\u2013645","journal-title":"N Engl J Med"},{"issue":"125\/126","key":"261_CR47","first-page":"129","volume":"27","author":"SM Cohen","year":"2001","unstructured":"Cohen SM (2001) Lead poisoning: a summary of treatment and prevention. Pediatr Nurs 27(125\/126):129\u2013130","journal-title":"Pediatr Nurs"},{"key":"261_CR48","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/lt.20621","volume":"11","author":"NR Pimstone","year":"2005","unstructured":"Pimstone NR (2005) Roles and pitfalls of transplantation in human porphyria. Liver Transpl 11:1460\u20131462","journal-title":"Liver Transpl"},{"key":"261_CR49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-200746040-00006","volume":"46","author":"E Sardh","year":"2007","unstructured":"Sardh E, Rejkjaer L, Andersson DE, Harper P (2007) Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. Clin Pharmacokinet 46:335\u2013349","journal-title":"Clin Pharmacokinet"},{"key":"261_CR50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jgm.1074","volume":"9","author":"M Yasuda","year":"2007","unstructured":"Yasuda M, Domaradzki ME, Armentano D et al (2007) Acute intermittent porphyria: vector optimization for gene therapy. J Gene Med 9:806\u2013811","journal-title":"J Gene Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-009-0261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-009-0261-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-009-0261-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:33:17Z","timestamp":1685010797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-009-0261-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,29]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1007\/s11739-009-0261-4","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,29]]}}}